INSP Quote, Financials, Valuation and Earnings

CONMED Corp. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of 0.84%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat CONMED Corp.'s return on equity of 6.56%.

Inspire Medical Systems, Inc. has a consensus price target of $119.40, signalling downside risk potential of -11.39%. On the other hand CONMED Corp. has an analysts' consensus of $56.00 which suggests that it could grow by 21.76%. Given that CONMED Corp. has higher upside potential than Inspire Medical Systems, Inc., analysts believe CONMED Corp. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.696, which suggesting that the stock is 30.412% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.977, suggesting its less volatile than the S&P 500 by 2.326%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 1.8% to investors and pays a quarterly dividend of $0.20 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are smaller than CONMED Corp. quarterly revenues of $338.6M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than CONMED Corp.'s net income of $2.9M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 92.43x while CONMED Corp.'s PE ratio is 21.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 4.59x versus 1.03x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Electromed, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of 12.65%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Electromed, Inc.'s return on equity of 18.89%.

Inspire Medical Systems, Inc. has a consensus price target of $119.40, signalling downside risk potential of -11.39%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 28.8%. Given that Electromed, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Electromed, Inc. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.696, which suggesting that the stock is 30.412% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Electromed, Inc.'s net income of $2.1M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 92.43x while Electromed, Inc.'s PE ratio is 30.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 4.59x versus 3.73x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Myomo, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of -36.3%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Myomo, Inc.'s return on equity of -68.35%.

Inspire Medical Systems, Inc. has a consensus price target of $119.40, signalling downside risk potential of -11.39%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 419.7%. Given that Myomo, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Myomo, Inc. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.696, which suggesting that the stock is 30.412% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.

Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 92.43x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 4.59x versus 0.95x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of 7.29%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Inspire Medical Systems, Inc. has a consensus price target of $119.40, signalling downside risk potential of -11.39%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 3.89%. Given that Phibro Animal Health Corp. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Phibro Animal Health Corp. is more attractive than Inspire Medical Systems, Inc..

Inspire Medical Systems, Inc. has a beta of 0.696, which suggesting that the stock is 30.412% less volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.12 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Inspire Medical Systems, Inc.'s net income of $9.9M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 92.43x while Phibro Animal Health Corp.'s PE ratio is 24.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 4.59x versus 1.21x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.